reatment Standards and Outcomes of Patients With ER/PR Positive HER2-negative Metastatic Breast Cancer
-
- STATUS
- Recruiting
-
- participants needed
- 300
-
- sponsor
- Hellenic Society of Medical Oncology
Summary
To capture the treatment patterns and clinical characteristics of patients with ER/PR positive, HER2-negative MBC in Greece
Description
- To capture the treatment patterns and clinical characteristics of patients with ER/PR
positive, HER2-negative MBC in Greece
- To evaluate the outcome of patients per treatment line (objective response, progression free survival, time to disease progression per line of therapy), overall survival
- To record adverse events per line of therapy
- To recording of the causes of treatment discontinuation per line of therapy
Details
| Condition | Metastatic Breast Cancer |
|---|---|
| Age | 18years - 100years |
| Clinical Study Identifier | NCT04247035 |
| Sponsor | Hellenic Society of Medical Oncology |
| Last Modified on | 19 February 2024 |
How to participate?
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreSimilar trials to consider
Browse trials for
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.